Carnegie Investment Counsel purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the first quarter, Holdings Channel reports. The firm purchased 46,917 shares of the financial services provider’s stock, valued at approximately $8,138,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Brighton Jones LLC raised its holdings in shares of Marsh & McLennan Companies by 51.2% during the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after acquiring an additional 2,960 shares during the period. Bison Wealth LLC raised its stake in Marsh & McLennan Companies by 39.6% during the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after purchasing an additional 869 shares during the period. Glenview Trust co boosted its holdings in Marsh & McLennan Companies by 10.8% in the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after purchasing an additional 379 shares during the last quarter. Osterweis Capital Management Inc. raised its position in shares of Marsh & McLennan Companies by 18,440.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock valued at $203,000 after buying an additional 922 shares during the period. Finally, Diversify Advisory Services LLC acquired a new position in Marsh & McLennan Companies in the second quarter valued at approximately $1,307,000. 87.99% of the stock is owned by institutional investors and hedge funds.
Marsh & McLennan Companies Price Performance
NYSE MRSH opened at $178.52 on Monday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $86.24 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 2.60 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $216.32.
Marsh & McLennan Companies Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Thursday, July 23rd will be issued a $0.99 dividend. This represents a $3.96 dividend on an annualized basis and a yield of 2.2%. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. The ex-dividend date is Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio (DPR) is 45.00%.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
MRSH has been the subject of several recent analyst reports. Cantor Fitzgerald raised their target price on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday. Wells Fargo & Company lowered their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a report on Thursday, April 9th. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. lowered their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research note on Thursday, April 9th. Finally, Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target on the stock in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Marsh & McLennan Companies currently has a consensus rating of “Hold” and an average target price of $200.44.
Get Our Latest Research Report on MRSH
More Marsh & McLennan Companies News
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: Cantor Fitzgerald raised its price target on Marsh & McLennan to $218 and reiterated an overweight rating, signaling strong upside expectations. Marsh & McLennan Companies (NYSE:MRSH) Given New $218.00 Price Target at Cantor Fitzgerald
- Positive Sentiment: Mizuho also lifted its price target to $197, keeping a neutral rating, which still reflects a more favorable valuation view. Marsh & McLennan Companies (NYSE:MRSH) Price Target Raised to $197.00 at Mizuho
- Positive Sentiment: UBS maintained its buy rating on Marsh & McLennan, reinforcing a broadly positive analyst stance on the shares. UBS Sticks to Their Buy Rating for Marsh & McLennan Companies (MRSH)
- Positive Sentiment: Marsh & McLennan increased its quarterly dividend by 10% to $0.99 per share, highlighting strong cash generation and shareholder-friendly capital allocation. Marsh Raises Dividend: Is Its Capital Return Story Getting Stronger?
- Neutral Sentiment: The company also declared the dividend formally for shareholders of record on July 23, which confirms the payout timing but is not a new catalyst. Marsh & McLennan Companies dividend announcement
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
